Colgate Palmolive (India) Limited — PPTs, 22-05-2026: Investor Presentation

Colgate-Palmolive India delivered a strong Q4 FY26, with Domestic Net Sales up 9.2% and NPAT rising 9.2% to ₹353 Cr. While full-year Net Sales were flat at ₹5,984 Cr with NPAT at ₹1,325 Cr, H2 saw a sharp 5.2% recovery. Gross and EBITDA margins remain resilient, showcasing financial discipline.

Strategy is centered on accelerating Oral Care premiumization, leading growth in toothpaste and toothbrushes, and expanding personal care. Initiatives include boosting consumption via rural pilots and education, strengthening core brands like Strong Teeth, and pushing premium products like Total and Visible White. Recent developments include Periogard's endorsement by the Indian Society of Periodontology.

The company is committed to consistent brand investments and operational efficiency, leveraging data and AI for strategic decisions. Management highlights a solid foundation for sustained long-term growth, focusing on category expansion and premium offerings.